Novartis Pharmaceuticals. Novartis Pharmaceuticals division has aimed for a 10-percent CO2 emissions reduction by 2010. Of the company's 8,000 fleet vehicles, 1,000 are E-85 Chevrolet Impalas, 555 are Toyota Prius hybrids, 100 are Saturn VUE Hybrids, and 42 are Ford Escape Hybrids. Toshiba America Medical Systems. Toshiba America Medical Systems (TAMS) in Tustin, Calif., is 100-percent certain hybrids are the preferred choice. The company's entire fleet of 500 leased vehicles will be replaced with hybrids during the next three years. Toshiba Corp. has set a 2010 global goal of reducing its energy-originated CO2 emissions by 25 percent, as well as non-CO2 GHG emissions by 35 percent. "By replacing our fleet with hybrid cars, we expect to reduce CO2 emissions from the vehicles by 25,000 lbs. and also save between $3,000-$4,000 in fuel during the lifecycle of each vehicle," said TAMS Manager of Fleet and Travel Administration, Jeff Berg. Originally posted on Automotive Fleet